Research

Found 91 results

Sort by: Author [ Title (Desc)] Year
Filters: First Letter Of Title is P  [Clear All Filters]
A B C D E F G H I J K L M N O [P] Q R S T U V W X Y Z   [Show ALL]
P
Holman P.  1995.  Pyridoxine – Vitamin B6. Journal of Australian College of Nutritional and Environmental Medicine. 14(1):5-16.
Wang HS, Kuo MF, Chou ML, Hung PC, Lin KL, Hsieh MY, Chang MY.  2005.  Pyridoxal Phosphate is Better than Pyridoxine for Controlling Idiopathic Intractable Epilepsy. Arch Dis Child.. 90(5):512-515.
Young A, Ruble L, McGrew J.  2009.  Public vs. Private Insurance: Cost, Use, Accessibility, and Outcomes of Services for Children with Autism Spectrum Disorders. Research in Autism Spectrum Disorders. 3(4):1023-1033. Abstract
Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE.  2008.  Psychotropic Medication Use among Medicaid-Enrolled Children with Autism Spectrum Disorders. Pediatrics. 121(3):e441-e448.
Jaklewicz H, Popek L.  2009.  Psychotherapy of Small Children. Archives of Psychiatry and Psychotherapy. 11(1):5-10. Abstract
Parikh MS, Kolevzon A, Hollander E.  2008.  Psychopharmacology of Aggression in Children and Adolescents with Autism: A Critical Review of Efficacy and Tolerability. Journal of Child and Adolescent Psychopharmacology. 18(2):157-178.
Hamrin V, McDonnell MA, Moffett J, Durso S.  2008.  Psychopharmacological Treatment of Non-Comorbid and Comorbid Pervasive Developmental Disorder and Pediatric Bipolar Disorder. Minerva Pediatrics. 60(1):87-101.
Bastiaansen D, Koot HM, Ferdinand RF.  2005.  Psychopathology in Children: Improvement of Quality of Life Without Psychiatric Symptom Reduction? Eur Child Adolesc Psychiatry. 14(7):364-370.
Mandell DS.  2008.  Psychiatric Hospitalization among Children with Autism Spectrum Disorders. J Autism Dev Disord. 38(6):1059-1065.
Forness SR, Walker HM, Kavale KA.  2003.  Psychiatric Disorders and Treatments: A Primer for Teachers. Teaching Exceptional Children. 36(2):42-49.
Gurkan K, Akcakin M, Kilic BG, Bilgic A.  2008.  Psychiatric Comorbidity and Drug Treatments in High Functioning Children and Adolescents with Pervasive Developmental Disorders. Neurology, Psychiatry, and Brain Research. 15:1-8.
Owley T, Salt J, Guter S, Grieve A, Walton L, Ayuyao N, Leventhal BL, Cook EH.  2006.  A Prospective, Open-Label Trial of Memantine in the Treatment of Cognitive, Behavioral, and Memory Dysfunction in Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5):517-524.
Nicolson R, Craven-Thuss B, Smith J.  2006.  A Prospective, Open-Label Trial of Galantamine in Autistic Disorder. Journal of Child and Adolescent Psychopharmacology. 16(5):621-629.
Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR.  2009.  A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders. Neurochem Res. 34(2):386-393.
Geier DA, Geier MR.  2007.  A Prospective Study of Mercury Toxicity Biomarkers in Autistic Spectrum Disorders. Journal of Toxicology and Environmental Health, Part A. 70(20):1723-1730.
Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B et al..  2006.  A Prospective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5):589-598.
Geier DA, Geier MR.  2007.  A Prospective Assessment of Androgen Levels in Patients with Autistic Spectrum Disorders: Biochemical Underpinnings and Suggested Therapies. Neuroendocrinology Letters. 28(5):565-573.
Lanter E, Watson LR.  2008.  Promoting Literacy in Students with ASD: The Basics for the SLP. Language, Speech, and Hearing Services in Schools. 39(1):33-43. Abstract
Schertz HH, Odom SL.  2007.  Promoting Joint Attention in Toddlers with Autism: A Parent-Mediated Developmental Model. J Autism Dev Disord. 37(8):1562-1575.
toy-play explore IA play, toy.  2003.  Promoting Early Play. Autism. 7(4):415-423.
Troost PW, Lahuis BE, Hermans MH, Buitelaar JK, vanEngeland H, Scahill L, Minderaa RB, Hoekstra PJ.  2007.  Prolactin Release in Children Treated with Risperidone. J Clin Psychopharmacology. 27(1):52-57.
Boulware G-L, Schwartz IS, Sandall SR, McBride BJ.  2006.  Project DATA for Toddlers: An Inclusive Approach to Very Young Children with Autism Spectrum Disorders. TECSE. 62(2):94-105.
Bibby P, Eikeseth S, Martin NT, Mudford OC, Reeves D.  2002.  Progress and Outcomes for Children with Autism Receiving Parent-Managed Intensive Interventions. Res Dev Disabil.. 23(1):81-104.
Horner RH, Carr EG, Strain PS, Todd AW, Reed HK.  2002.  Problem Behavior Interventions for Young Children with Autism: A Research Synthesis. Journal of Autism and Developmental Disorders. 32(5):423-446.
Kaur IP, Kuhad A, Garg A, Chopra K.  2009.  Probiotics: Delineation of Prophylactic and Therapeutic Benefits. Journal of Medicinal Food. 12(2):219-235.
|